Up a level |
Giudici, Nicola; Blarer, Jennifer; Sathianathen, Niranjan; Burkhard, Fiona C.; Wüthrich, Patrick Y.; Thalmann, George N.; Seiler, Roland; Furrer, Marc A. (2024). Diagnostic Value of Urine Cytology in Pharmacologically Forced Diuresis for Upper Tract Urothelial Carcinoma Diagnosis and Follow-Up. Cancers, 16(4) MDPI AG 10.3390/cancers16040758
Christensen, Emil; Wyatt, Alexander W; Galsky, Matthew D; Grivas, Petros; Seiler, Roland; Nawroth, Roman; Goebell, Peter J; Schmitz-Drager, Bernd J; Williams, Stephen B; Black, Peter C; Kamat, Ashish M; Todenhöfer, Tilman; Dyrskjøt, Lars (2023). IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer. Urologic oncology - seminars and original investigations, 41(7), pp. 318-322. Elsevier 10.1016/j.urolonc.2022.11.008
Hensley, Patrick J; Seiler, Roland; Herr, Harry; Mouw, Kent W; Iyer, Gopa; Dyrskjøt, Lars; Nawroth, Roman; Goebell, Peter; Schmitz-Drager, Bernd; Todenhofer, Tilman; Black, Peter C; Kamat, Ashish M; Williams, Stephen B (2023). Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1. Urologic oncology - seminars and original investigations, 41(7), pp. 307-312. Elsevier 10.1016/j.urolonc.2023.01.001
Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S (2023). Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]. European urology, 83(6), e165. Elsevier 10.1016/j.eururo.2023.03.002
Seiler, Roland; Egger, Martin; De Menna, Marta; Wehrli, Saskia; Minoli, Martina; Radić, Martina; Lyatoshinsky, Pavel; Hösli, Raphael; Blarer, Jennifer; Abt, Dominik; Kruithof-de Julio, Marianna (2023). Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial. BMC urology, 23(1), p. 89. BMC 10.1186/s12894-023-01262-1
Minoli, Martina; Cantore, Thomas; Hanhart, Daniel; Kiener, Mirjam; Fedrizzi, Tarcisio; La Manna, Federico; Karkampouna, Sofia; Chouvardas, Panagiotis; Genitsch, Vera; Rodriguez-Calero, Antonio; Compérat, Eva; Klima, Irena; Gasperini, Paola; Kiss, Bernhard; Seiler, Roland; Demichelis, Francesca; Thalmann, George N; Kruithof-de Julio, Marianna (2023). Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nature Communications, 14(1), p. 2214. Springer Nature 10.1038/s41467-023-37696-2
Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S (2023). Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European urology, 83(4), pp. 313-317. Elsevier 10.1016/j.eururo.2022.07.023
Egger, Martin; Seiler, Roland (2023). Which Patients To Consider for Bladder Preservation After a Complete Response to Neoadjuvant Chemotherapy. European urology focus, 9(2), pp. 229-231. Elsevier 10.1016/j.euf.2023.01.023
Marcq, Gautier; Afferi, Luca; Neuzillet, Yann; Nykopp, Timo; Voskuilen, Charlotte S; Furrer, Marc A; Kassouf, Wassim; Aziz, Atiqullah; Bajeot, Anne Sophie; Alvarez-Maestro, Mario; Black, Peter; Roupret, Morgan; Noon, Aidan P; Seiler, Roland; Hendricksen, Kees; Roumiguie, Mathieu; Pang, Karl H; Laine-Caroff, Paul; Xylinas, Evanguelos; Ploussard, Guillaume; ... (2022). Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group. Cancers, 14(23) MDPI AG 10.3390/cancers14235740
Furrer, Marc A.; Papa, Nathan; Luetolf, Sandro; Roth, Beat; Cumberbatch, Marcus; Dorin Vartolomei, Mihai; Thomas, Benjamin C.; Thoeny, Harriet C.; Seiler, Roland; Thalmann, George N.; Kiss, Bernhard (2022). A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer. BJU international, 130(3), pp. 306-313. Wiley 10.1111/bju.15579
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha; Montgomery, Bruce; Seiler, Roland; Black, Peter C; Boormans, Joost L; Dall'Era, Marc; Davincioni, Elai; Douglas, James; Gibb, Ewan A; van Rhijn, Bas W G; van der Heijden, Michiel S; Hsiehc, Andrew C; Wrighta, Jonathan L; Lam, Hung-Ming (2022). Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urologic oncology, 40(7), p. 352. Elsevier 10.1016/j.urolonc.2022.05.011
Ahmed, Mohamed E; Todenhöfer, Tilman; Karnes, R Jeffrey; Seiler, Roland (2022). Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers. European urology focus, 8(3), pp. 663-666. Elsevier 10.1016/j.euf.2022.06.009
Giudici, Nicola; Bonne, Fieke; Blarer, Jennifer; Minoli, Martina; Friedemann Krentel, Andreas; Seiler, Roland (2021). Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review. Translational andrology and urology, 10(10), pp. 4036-4050. AME Publishing Company 10.21037/tau-20-1472
Beyer, Jörg; Berthold, Dominik; Bode, Peter-Karl; Cathomas, Richard; Fankhauser, Christian D; Fischer, Stefanie; Gillessen, Silke; Gross, Tobias; Hermanns, Thomas; Honecker, Friedemann; Lorch, Anja; Omlin, Aurelius; Papachristofilou, Alexandros; Roth, Beat; Rothermundt, Christian; Seiler, Roland; Spahn, Martin; Stenner, Frank; Bührer, Emanuel (2021). Swiss germ-cell cancer consensus recommendations. Swiss medical weekly, 151(33-34) EMH Schweizerischer Ärzteverlag 10.4414/SMW.2021.w30023
Furrer, Marc A.; Kiss, Bernhard; Studer, Urs E.; Wuethrich, Patrick Y.; Gahl, Brigitta; Seiler, Roland; Roth, Beat; Bosshard, Piet; Thomas, Benjamin C; Burkhard, Fiona C.; Boxler, Silvan; Thalmann, George N. (2021). Seminal Vesical Sparing Cystectomy in Bladder Cancer Patients is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center Study. Journal of urology, 205(6), pp. 1629-1640. Elsevier 10.1097/JU.0000000000001635
Krentel, Friedemann; Singer, Franziska; Rosano-Gonzalez, María Lourdes; Gibb, Ewan A; Liu, Yang; Davicioni, Elai; Keller, Nicola; Stekhoven, Daniel J; Kruithof-de Julio, Marianna; Seiler-Blarer, Roland (2021). A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer. Scientific Reports, 11(1), p. 5849. Nature Publishing Group 10.1038/s41598-021-85151-3
Black, Peter C; Goebell, Peter J; Kamat, Ashish M; Nawroth, Roman; Seiler, Roland; Williams, Stephen B; Schmitz-Dräger, Bernd J (2020). Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series. Urologic oncology - seminars and original investigations, 38(12), pp. 855-857. Elsevier 10.1016/j.urolonc.2019.01.003
Boormans, Joost L; Zwarthoff, Ellen C; Black, Peter C; Goebell, Peter J; Kamat, Ashish M; Nawroth, Roman; Seiler, Roland; Williams, Stephen B; Schmitz-Dräger, Bernd J (2020). New horizons in bladder cancer research. Urologic oncology - seminars and original investigations, 38(12), pp. 867-885. Elsevier 10.1016/j.urolonc.2018.12.014
Krentel, Friedemann; Seiler, Roland (2020). Re: A Clonal Expression Biomarker Associates with Lung Cancer Mortality. European urology, 78(6), pp. 925-926. Elsevier 10.1016/j.eururo.2020.06.027
Voskuilen, Charlotte S; Seiler, Roland; Rink, Michael; Poyet, Cédric; Noon, Aidan P; Roghmann, Florian; Necchi, Andrea; Aziz, Atiqullah; Lavollé, Alexandre; Young, Matthew J; Marks, Phillip; Saba, Karim; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Ablat, Jason; Black, Peter C; Sosnowski, Roman; Dobruch, Jakub; Kumar, Pardeep; Jallad, Samer; ... (2020). Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes. European urology focus, 6(6), pp. 1226-1232. Elsevier 10.1016/j.euf.2018.12.002
Tully, Karl H; Moschini, Marco; von Rundstedt, Friedrich-Carl E; Aziz, Atiqullah; Kluth, Luis A; Necchi, Andrea; Rink, Michael; Hendricksen, Kees; Sargos, Paul; Vetterlein, Malte W; Seiler, Roland; Poyet, Cedric; Krajewski, Wojciech; Fajkovic, Harun; Shariat, Shahrokh F; Xylinas, Evanguelos; Roghmann, Florian (2020). Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. Urologic oncology, 38(11), 851.e19-851.e25. Elsevier 10.1016/j.urolonc.2020.06.034
Dobé, T; Ouzaid, I; Califano, G; Von Rundstedt, F; Albisinni, S; Aziz, A; Di Trapani, E; Hendricksen, K; Krajewski, W; Mari, A; Moschini, M; Necchi, A; Moon, A; Poyet, C; Pradère, B; Rink, M; Roghmann, F; Sargos, P; Seiler, R. and Xylinas, E (2020). Défaut d’adoption de l’instillation intravésicale postopératoire précoce de chimiothérapie après néphro-urétérectomie totale. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 30(13), p. 822. Elsevier 10.1016/j.purol.2020.07.215
Gleave, Martin E; Kawai, Yoshihisa; Imada, Kenjiro; Akamatsu, Shusuke; Zhang, Fan; Seiler, Roland; Hayashi, Tetsutaro; Leong, Jeffrey; Beraldi, Eliana; Saxena, Neetu; Kretschmer, Alexander; Oo, Htoo Zarni; Contreras-Sanz, Alberto; Matsuyama, Hideyasu; Lin, Dong; Fazli, Ladan; Collins, Colin C; Wyatt, Alexander W; Black, Peter C (2020). Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion and Survival of Bladder Cancer. Molecular cancer therapeutics, 19(10), pp. 2210-2220. American Association for Cancer Research AACR 10.1158/1535-7163.MCT-19-1031
Gild, Philipp; Vetterlein, Malte W; Seiler, Roland; Necchi, Andrea; Hendricksen, Kees; Mertens, Laura S; Roghmann, Florian; Landenberg, Nicolas V; Gontero, Paolo; Cumberbatch, Marcus; Dobruch, Jakub; Seisen, Thomas; Grande, Pietro; D'Andrea, David; Anract, Julien; Comploj, Evi; Pycha, Armin; Saba, Karim; Poyet, Cedric; van Rhijn, Bas W; ... (2020). The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group. Surgical oncology, 34, pp. 312-317. Elsevier 10.1016/j.suronc.2020.06.006
Minoli, Martina; Kiener, Mirjam; Thalmann, George N.; Kruithof-de Julio, Marianna; Seiler, Roland (2020). Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications. International journal of molecular sciences, 21(16) MDPI 10.3390/ijms21165670
de Jong, Joep J; Boormans, Joost L; van Rhijn, Bas W G; Seiler, Roland; Boorjian, Stephen A; Konety, Badrinath; Bivalacqua, Trinity J; Wheeler, Thomas; Svatek, Robert S; Douglas, James; Wright, Jonathan; Dall'Era, Marc; Crabb, Simon J; Efstathiou, Jason A; van der Heijden, Michiel S; Mouw, Kent W; Miyamoto, David T; Lotan, Yair; Black, Peter C; Gibb, Ewan A; ... (2020). Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European urology oncology, 3(4), pp. 420-423. Elsevier 10.1016/j.euo.2020.02.010
Jalanko, Tuomas; de Jong, Joep J; Gibb, Ewan A; Seiler, Roland; Black, Peter C (2020). Correction to: Genomic Subtyping in Bladder Cancer. Current urology reports, 21(7), p. 25. Springer 10.1007/s11934-020-00977-0
Kamoun, Aurélie; de Reyniès, Aurélien; Allory, Yves; Sjödahl, Gottfrid; Robertson, A Gordon; Seiler, Roland; Hoadley, Katherine A; Groeneveld, Clarice S; Al-Ahmadie, Hikmat; Choi, Woonyoung; Castro, Mauro A A; Fontugne, Jacqueline; Eriksson, Pontus; Mo, Qianxing; Kardos, Jordan; Zlotta, Alexandre; Hartmann, Arndt; Dinney, Colin P; Bellmunt, Joaquim; Powles, Thomas; ... (2020). A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. European urology, 77(4), pp. 420-433. Elsevier 10.1016/j.eururo.2019.09.006
Grivas, Petros; Bismar, Tarek A; Alva, Aijai S; Huang, Huei-Chung; Liu, Yang; Seiler, Roland; Alimohamed, Nimira; Cheng, Liang; Hyndman, M Eric; Dabbas, Bashar; Black, Peter C; Davicioni, Elai; Wright, Jonathan L; Ornstein, Moshe C; Mian, Omar Y; Kaimakliotis, Hristos Z; Gibb, Ewan A; Lotan, Yair (2020). Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. Urologic oncology, 38(4), pp. 262-268. Elsevier 10.1016/j.urolonc.2019.11.004
Williams, Stephen B; Black, Peter C; Dyrskjøt, Lars; Seiler, Roland; Schmitz-Dräger, Bernd; Nawroth, Roman; Todenhöfer, Tilman; Kamat, Ashish M; Goebell, Peter J (2020). Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420-33: A Statement from the International Bladder Cancer Network. European urology, 77(4), e105-e106. Elsevier 10.1016/j.eururo.2019.11.011
Jalanko, Tuomas; de Jong, Joep J; Gibb, Ewan A; Seiler, Roland; Black, Peter C (2020). Genomic Subtyping in Bladder Cancer. Current urology reports, 21(2), p. 9. Springer 10.1007/s11934-020-0960-y
Kamoun, Aurélie; de Reyniès, Aurélien; Allory, Yves; Sjödahl, Gottfrid; Robertson, A Gordon; Seiler, Roland; Hoadley, Katherine A; Groeneveld, Clarice S; Al-Ahmadie, Hikmat; Choi, Woonyoung; Castro, Mauro A A; Fontugne, Jacqueline; Eriksson, Pontus; Mo, Qianxing; Kardos, Jordan; Zlotta, Alexandre; Hartmann, Arndt; Dinney, Colin P; Bellmunt, Joaquim; Powles, Thomas; ... (2020). Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. European urology, 77(4), pp. 436-438. Elsevier 10.1016/j.eururo.2019.12.014
Voskuilen, Charlotte S; Oo, Htoo Zarni; Genitsch Gratwohl, Vera; Smit, Laura A; Vidal, Alvaro; Meneses, Manuel; Necchi, Andrea; Colecchia, Maurizio; Xylinas, Evanguelos; Fontugne, Jacqueline; Sibony, Mathilde; Rouprêt, Morgan; Lenfant, Louis; Côté, Jean-François; Buser, Lorenz; Saba, Karim; Furrer, Marc A.; van der Heijden, Michiel S; Daugaard, Mads; Black, Peter C; ... (2019). Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. The American journal of surgical pathology, 43(12), pp. 1600-1610. Lippincott Williams & Wilkins 10.1097/PAS.0000000000001371
Fantini, Damiano; Seiler, Roland; Meeks, Joshua J (2019). Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients. Urologic oncology - seminars and original investigations, 37(11), pp. 818-825. Elsevier 10.1016/j.urolonc.2018.09.017
Seiler, Roland; Wyatt, Alexander W; Black, Peter C (2019). Molecular landscape of muscle-invasive bladder cancer: Patient age matter? BJU international, 124(5), pp. 719-721. Wiley 10.1111/bju.14802
Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Wyatt, Alexander W; Gibb, Ewan A; Kruithof-de Julio, Marianna; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(11), pp. 826-836. Elsevier 10.1016/j.urolonc.2019.09.025
Seiler, Roland; Black, Peter C; Williams, Stephen B; Goebell, Peter J; Kamat, Ashish M; Nawroth, Roman; Schmitz-Dräger, Bernd J (2019). Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series. Urologic oncology - seminars and original investigations, 37(11), pp. 815-817. Elsevier 10.1016/j.urolonc.2019.06.025
de Jong, Joep J; Liu, Yang; Robertson, A Gordon; Seiler, Roland; Groeneveld, Clarice S; van der Heijden, Michiel S; Wright, Jonathan L; Douglas, James; Dall'Era, Marc; Crabb, Simon J; van Rhijn, Bas W G; van Kessel, Kim E M; Davicioni, Elai; Castro, Mauro A A; Lotan, Yair; Zwarthoff, Ellen C; Black, Peter C; Boormans, Joost L; Gibb, Ewan A (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome medicine, 11(1), p. 60. BioMed Central 10.1186/s13073-019-0669-z
Schardt, Julian; Roth, Beat; Seiler, Roland (2019). Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when? World journal of urology, 37(9), pp. 1759-1765. Springer-Verlag 10.1007/s00345-018-2544-8
Blarer, Jennifer; Furrer, Marc; Roth, Beat; Wüthrich, P. Y.; Burkhard, Fiona; Thalmann, George N.; Seiler, Roland (20 August 2019). Nutzen der Urinzytologie mit forcierter Diurese zum follow-up des Urothelkarzinoms im oberen Harntrakt? Der Urologe, 58, S30-S30. Springer
Seiler, Roland; Gibb, Ewan A; Wang, Natalie Q; Oo, Htoo Zarni; Lam, Hung-Ming; Van Kessel, Kim E; Winters, Brian; Erho, Nicholas G; Takhar, Mandeep M; Douglas, James; Vakar-Lopez, Funda; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Zwarthoff, Ellen C; Thalmann, George; Boormans, Joost L; Dall'Era, Marc; van der Heijden, Michiel S; Wright, Jonathan L and Black, Peter C (2019). Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clinical cancer research, 25(16), pp. 5082-5093. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1106
Batista da Costa, José; Gibb, Ewan A; Bivalacqua, Trinity J; Liu, Yang; Oo, Htoo Zarni; Miyamoto, David T; Alshalalfa, Mohammed; Davicioni, Elai; Wright, Jonathan; Dall'Era, Marc A; Douglas, James; Boormans, Joost L; Van der Heijden, Michiel S; Wu, Chin-Lee; van Rhijn, Bas W G; Gupta, Shilpa; Grivas, Petros; Mouw, Kent W; Murugan, Paari; Fazli, Ladan; ... (2019). Molecular Characterization of Neuroendocrine-like Bladder Cancer. Clinical cancer research, 25(13), pp. 3908-3920. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3558
Hendricksen, Kees; Aziz, Atiqullah; Bes, Perrine; Chun, Felix K-H; Dobruch, Jakub; Kluth, Luis A; Gontero, Paolo; Necchi, Andrea; Noon, Aidan P; van Rhijn, Bas W G; Rink, Michael; Roghmann, Florian; Rouprêt, Morgan; Seiler, Roland; Shariat, Shahrokh F; Qvick, Brian; Babjuk, Marek; Xylinas, Evanguelos (2019). Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. European urology focus, 5(4), pp. 681-688. Elsevier 10.1016/j.euf.2017.09.002
Efstathiou, Jason A; Mouw, Kent W; Gibb, Ewan A; Liu, Yang; Wu, Chin-Lee; Drumm, Michael R; da Costa, Jose Batista; du Plessis, Marguerite; Wang, Natalie Q; Davicioni, Elai; Feng, Felix Y; Seiler, Roland; Black, Peter C; Shipley, William U; Miyamoto, David T (2019). Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer. European urology, 76(1), pp. 59-68. Elsevier 10.1016/j.eururo.2019.01.011
Hupe, M C; Gakis, G; Seiler, Roland (2019). [Molecular tumor board-urothelial cancer]. Der Urologe, 58(7), pp. 760-767. Springer 10.1007/s00120-019-0967-5
Todenhöfer, Tilman; Seiler, Roland (2019). Molecular subtypes and response to immunotherapy in bladder cancer patients. Translational andrology and urology, 8(Suppl 3), S293-S295. AME Publishing Company 10.21037/tau.2019.06.21
Krentel, A. F.; Singer, F.; Gibb, E.; Yang, L.; Davicioni, E.; Kruithof-de Julio, M.; Seiler, R. (15 March 2019). The genomic landscape of muscle-invasive bladder cancer enables a personalized in silico drug discovery. European Urology Supplements, 18(1), e591-e591. Elsevier 10.1016/S1569-9056(19)30438-5
Genitsch, V.; Kollár, A.; Blarer, J.; Vandekerkhove, G.; Furrer, M.; Krentel, A.; Gibb, E.; Davicioni, E.; Wyatt, A.; Seiler, R. (15 March 2019). Molecular decoding of sarcomatoid variant of muscle-invasive bladder cancer might reveal treatment strategies. European Urology Supplements, 18(1), e1449-e1449. Elsevier 10.1016/S1569-9056(19)31044-9
Williams, Stephen B; Hudgins, Hogan K; Ray-Zack, Mohamed D; Chamie, Karim; Smaldone, Marc C; Boorjian, Stephen A; Daneshmand, Siamak; Black, Peter C; Kamat, Ashish M; Goebell, Peter J; Seiler, Roland; Schmitz-Drager, Bernd; Nawroth, Roman; Baillargeon, Jacques; Klaassen, Zachary; Kulkarni, Girish S; Kim, Simon P; Lee, Eugene K; Holzbeierlein, Jeffrey M; Hollenbeck, Brent K; ... (2019). Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. European urology oncology, 2(2), pp. 119-125. Elsevier 10.1016/j.euo.2018.07.006
Todenhöfer, Tilman; Miernik, Arkadiusz; Seiler, Roland (2019). [High-throughput molecular analysis of urothelial carcinoma: potential clinical applications]. Aktuelle Urologie, 50(1), pp. 84-93. Thieme 10.1055/a-0755-7284
Faba, Oscar Rodríguez; Tyson, Mark D; Artibani, Walter; Bochner, Bernard H; Burkhard, Fiona C.; Gilbert, Scott M; Kälble, Tilman; Madersbacher, Stephan; Seiler, Roland; Skinner, Ella C; Thalmann, George; Thüroff, Joachim; Wiklund, Peter; Hautmann, Richard; Palou, Joan (2019). Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion. World journal of urology, 37(1), pp. 85-93. Springer-Verlag 10.1007/s00345-018-2484-3
Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J.; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Gibb, Ewan A.; Kruithof-de Julio, Marianna; Wyatt, Alexander W.; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(9), 573.e19-573.e29. Elsevier 10.1016/j.urolonc.2019.06.021
Kiener, M.; Karkampouna, S.; Thalmann, G. N.; Seiler, R.; Kruithof-de Julio, M. (2019). Characterisation of bladder cancer drug responses in organoids and ex vivo models. Der Urologe, 58(Suppl 1), S101-S101. Springer
Krentel, F.; Singer, F.; Gibb, E. A.; Liu, Y.; Davicioni, E.; Kruithof-de Julio, M.; Seiler, R. (2019). Medikamentöse Tumortherapie für das muskelinvasive Blasenkarzinom basierend auf dessen genetischen Profil. Der Urologe, 58(Suppl 1), S100-S100. Springer
Oo, Htoo Zarni; Seiler, Roland; Black, Peter C; Daugaard, Mads (2018). Post-translational modifications in bladder cancer: Expanding the tumor target repertoire. Urologic oncology - seminars and original investigations, 38(12), pp. 858-866. Elsevier 10.1016/j.urolonc.2018.09.001
Hermans, Tom J N; Voskuilen, Charlotte S; van der Heijden, Michiel S; Schmitz-Dräger, Bernd J; Kassouf, Wassim; Seiler, Roland; Kamat, Ashish M; Grivas, Petros; Kiltie, Anne E; Black, Peter C; van Rhijn, Bas W G (2018). Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future. Urologic oncology - seminars and original investigations, 36(9), pp. 413-422. Elsevier 10.1016/j.urolonc.2017.10.014
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha; Montgomery, Bruce; Seiler, Roland; Black, Peter C; Boormans, Joost L; Dall Era, Marc; Davincioni, Elai; Douglas, James; Gibb, Ewan A; van Rhijn, Bas W G; van der Heijden, Michiel S; Hsieh, Andrew C; Wright, Jonathan L; Lam, Hung-Ming (2018). Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urologic oncology - seminars and original investigations, 36(7), 342.e7-342.e14. Elsevier 10.1016/j.urolonc.2018.03.016
Seiler, Roland; Thalmann, George (2018). Robot-assisted versus open cystectomy. Lancet, 391(10139), pp. 2479-2480. Elsevier 10.1016/S0140-6736(18)31309-6
Goriki, Akihiro; Seiler, Roland; Wyatt, Alexander W; Contreras-Sanz, Alberto; Bhat, Akshay; Matsubara, Akio; Hayashi, Tetsutaro; Black, Peter C (2018). Unravelling disparate roles of NOTCH in bladder cancer. Nature Reviews. Urology, 15(6), pp. 345-357. Nature Publishing Group 10.1038/s41585-018-0005-1
von Landenberg, Nicolas; Aziz, Atiqullah; von Rundstedt, Friedrich C; Dobruch, Jakub; Kluth, Luis A; Necchi, Andrea; Noon, Aidan; Rink, Michael; Hendricksen, Kees; Decaestecker, Karel P J; Seiler, Roland; Poyet, Cédric; Fajkovic, Harun; Shariat, Shahrokh F; Xylinas, Evanguelos; Roghmann, Florian (2018). Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 36(5), 238.e19-238.e27. Elsevier 10.1016/j.urolonc.2018.01.017
Todenhöfer, Tilman; Struss, Werner J; Seiler, Roland; Wyatt, Alexander William; Black, Peter C (2018). Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder cancer, 4(1), pp. 19-29. IOS Press 10.3233/BLC-170140
Zhao, Shuang G; Chang, S Laura; Erho, Nicholas; Yu, Menggang; Lehrer, Jonathan; Alshalalfa, Mohammed; Speers, Corey; Cooperberg, Matthew R; Kim, Won; Ryan, Charles J; Den, Robert B; Freedland, Stephen J; Posadas, Edwin; Sandler, Howard; Klein, Eric A; Black, Peter; Seiler, Roland; Tomlins, Scott A; Chinnaiyan, Arul M; Jenkins, Robert B; ... (2017). Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA oncology, 3(12), pp. 1663-1672. American Medical Association 10.1001/jamaoncol.2017.0751
Ineichen, Gallus Beatus; Röthlisberger, Raphael; Johner, Kevin Fabian; Seiler, Roland (2017). Different stages in drug development for muscle-invasive bladder cancer. Translational andrology and urology, 6(6), pp. 1060-1066. AME Publishing Company 10.21037/tau.2017.11.22
Seiler, Roland; Ashab, Hussam Al Deen; Erho, Nicholas; van Rhijn, Bas W G; Winters, Brian; Douglas, James; Van Kessel, Kim E; Fransen van de Putte, Elisabeth E; Sommerlad, Matthew; Wang, Natalie Q; Choeurng, Voleak; Gibb, Ewan A; Palmer-Aronsten, Beatrix; Lam, Lucia L; Buerki, Christine; Davicioni, Elai; Sjödahl, Gottfrid; Kardos, Jordan; Hoadley, Katherine A; Lerner, Seth P; ... (2017). Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European urology, 72(4), pp. 544-554. Elsevier 10.1016/j.eururo.2017.03.030
Aziz, Atiqullah; Dobruch, Jakub; Hendricksen, Kees; Kluth, Luis A; Necchi, Andrea; Noon, Aidan; Rink, Michael; Roghmann, Florian; Seiler, Roland; Gontero, Paolo; Kassouf, Wassim; Shariat, Shahrokh F; Xylinas, Evanguelos (2017). Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. World journal of urology, 35(9), pp. 1401-1407. Springer 10.1007/s00345-016-1995-z
Alshalalfa, Mohammed; Verhaegh, Gerald W; Gibb, Ewan A; Santiago-Jiménez, Maria; Erho, Nicholas; Jordan, Jennifer; Yousefi, Kasra; Lam, Lucia L C; Kolisnik, Tyler; Chelissery, Jijumon; Seiler, Roland; Ross, Ashley E; Karnes, R Jeffrey; Schaeffer, Edward M; Lotan, Tamara T; Den, Robert B; Freedland, Stephen J; Davicioni, Elai; Klein, Eric A and Schalken, Jack A (2017). Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. OncoTarget, 8(31), pp. 50804-50813. Impact Journals LLC 10.18632/oncotarget.15133
Genitsch Gratwohl, Vera; Zlobec, Inti; Seiler, Roland; Thalmann, George; Fleischmann, Achim (2017). Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors. International journal of molecular sciences, 18(8) Molecular Diversity Preservation International MDPI 10.3390/ijms18081640
Korpal, Manav; Puyang, Xiaoling; Jeremy Wu, Zhenhua; Seiler, Roland; Furman, Craig; Oo, Htoo Z; Seiler, Michael; Irwin, Sean; Subramanian, Vanitha; Julie Joshi, Jaya; Wang, Chris K; Rimkunas, Victoria; Tortora, Davide; Yang, Hua; Kumar, Namita; Kuznetsov, Galina; Matijevic, Mark; Chow, Jesse; Kumar, Pavan; Zou, Jian; ... (2017). Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer. Nature communications, 8(1), p. 103. Nature Publishing Group 10.1038/s41467-017-00147-w
Seiler, Roland; Black, Peter C; Thalmann, George; Stenzl, Arnulf; Todenhöfer, Tilman (2017). Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer? Urologic oncology - seminars and original investigations, 35(7), 458.e1-458.e7. Elsevier 10.1016/j.urolonc.2017.01.024
Seiler, Roland; Oo, Htoo Zarni; Tortora, Davide; Clausen, Thomas M; Wang, Chris K; Kumar, Gunjan; Pereira, Marina Ayres; Ørum-Madsen, Maj S; Agerbæk, Mette Ø; Gustavsson, Tobias; Nordmaj, Mie A; Rich, Jamie R; Lallous, Nada; Fazli, Ladan; Lee, Sherry S; Douglas, James; Todenhöfer, Tilman; Esfandnia, Shaghayegh; Battsogt, Dulguun; Babcook, John S; ... (2017). An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. European urology, 72(1), pp. 142-150. Elsevier 10.1016/j.eururo.2017.03.021
Nussberger, Fabio Victor; Roth, Beat; Metzger, Tobias Alfred; Kiss, Bernhard; Thalmann, George; Seiler, Roland (2017). A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones. Urolithiasis, 45(3), pp. 317-321. Springer 10.1007/s00240-016-0915-4
Kretschmer, Alexander; Hüsch, Tanja; Thomsen, Frauke; Kronlachner, Dominik; Obaje, Alice; Anding, Ralf; Pottek, Tobias; Rose, Achim; Olianas, Roberto; Friedl, Alexander; Hübner, Wilhelm; Homberg, Roland; Pfitzenmaier, Jesco; Queissert, Fabian; Naumann, Carsten M; Wotzka, Carola; Hofmann, Torben; Seiler, Roland; Haferkamp, Axel and Bauer, Ricarda M (2017). Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Perioperative Complications and Device Explantations. International neurourology journal, 21(2), pp. 109-115. Korean Continence Society 10.5213/inj.1632626.313
Kiss, Bernhard; Wyatt, Alexander W; Douglas, James; Skuginna, Veronika Olga; Mo, Fan; Anderson, Shawn; Rotzer, Diana; Fleischmann, Achim; Genitsch Gratwohl, Vera; Hayashi, Tetsutaro; Neuenschwander, Maja; Buerki, Christine; Davicioni, Elai; Collins, Colin; Thalmann, George; Black, Peter C; Seiler, Roland (2017). Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy. Scientific Reports, 7(42713), p. 42713. Nature Publishing Group 10.1038/srep42713
Contreras-Sanz, Alberto; Roberts, Morgan E; Seiler, Roland; Black, Peter C (2017). Recent progress with next-generation biomarkers in muscle-invasive bladder cancer. International journal of urology, 24(1), pp. 7-15. Wiley 10.1111/iju.13193
Ho, Melissa E; Quek, Sue-Ing; True, Lawrence D; Seiler, Roland; Fleischmann, Achim; Bagryanova, Lora; Kim, Sara R; Chia, David; Goodglick, Lee; Shimizu, Yoshiko; Rosser, Charles J; Gao, Yuqian; Liu, Alvin Y (2016). Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2. OncoTarget, 7(13), pp. 15747-15756. Impact Journals LLC 10.18632/oncotarget.7400
Skuginna, Veronika; Nguyen, Daniel Truong Phat; Seiler, Roland; Kiss, Bernhard; Thalmann, George; Roth, Beat (2016). Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial. European urology, 69(2), pp. 267-273. Elsevier 10.1016/j.eururo.2015.06.017
Tschui, Joëlle; Vassella, Erik; Bandi Hess, Nora; Baumgartner, Ulrich; Genitsch Gratwohl, Vera; Rotzer, Diana; Seiler, Roland; Thalmann, George; Fleischmann, Achim (2015). Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer. Virchows Archiv, 466(6), pp. 703-710. Springer 10.1007/s00428-015-1729-4
Nguyen, Daniel Truong Phat; Hnilicka, Stefanie; Kiss, Bernhard; Seiler, Roland; Thalmann, George; Roth, Beat (2015). Optimization of extracorporeal shock wave lithotripsy delivery rates achieves excellent outcomes in ureteral stones. Results of a prospective, randomized trial. Journal of urology, 194(2), pp. 418-423. Elsevier 10.1016/j.juro.2015.01.110
Kiss, Bernhard; Skuginna, Veronika; Fleischmann, Achim; Bell, Robert H; Collins, Colin; Thalmann, George; Seiler, Roland (2015). Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder. Urologic oncology - seminars and original investigations, 33(4), 166.e1-166.e8. Elsevier 10.1016/j.urolonc.2014.12.005
Turo, Rafal; Harnden, Patricia; Thygesen, Helene; Fleischmann, Achim; Thalmann, George; Seiler, Roland; Cross, William R; Knowles, Margaret A (2015). FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases. Journal of urology, 193(1), pp. 325-330. Elsevier 10.1016/j.juro.2014.06.026
Fleischmann, Achim; Saramäki, Outi R; Zlobec, Inti; Rotzer, Diana; Genitsch Gratwohl, Vera; Seiler, Roland; Visakorpi, Tapio; Thalmann, George (2014). Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers. Prostate, 74(16), pp. 1647-1654. Wiley-Blackwell 10.1002/pros.22882
Seiler, Roland; Studer, Urs E.; Tschan, Konrad; Bader, Pia; Burkhard, Fiona C. (2014). Removal of Limited Nodal Disease in Patients Undergoing Radical Prostatectomy: Long-Term Results Confirm a Chance for Cure. Journal of urology, 191(5), pp. 1280-1285. Elsevier 10.1016/j.juro.2013.11.029
Fleischmann, Achim; Thalmann, George; Perren, Aurel; Seiler, Roland (2014). Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival. The American journal of surgical pathology, 38(3), pp. 325-332. Lippincott Williams & Wilkins 10.1097/PAS.0000000000000142
Seiler, Roland; Thalmann, George N.; Rotzer, Diana; Perren, Aurel; Fleischmann, Achim (2014). CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Modern pathology, 27(1), pp. 87-95. Nature Publishing Group 10.1038/modpathol.2013.125
Nguyen, Daniel P.; Giannarini, Gianluca; Seiler, Roland; Schiller, Rike; Thoeny, Harriet C.; Thalmann, George N.; Studer, Urs E. (2013). Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site. BJU international, 112(4), E243-E249. Blackwell Science 10.1111/j.1464-410X.2012.11506.x
Fleischmann, Achim; Seiler, Roland; Zlobec, Inti; Visakorpi, Tapio; Thalmann, George (April 2013). TMPRSS2-ERG Gene Fusion: Frequency and Prognostic Significance in Prostate Cancer Patients with Positive Lymph Nodes. Journal of urology, 189(4), E84-E85. Elsevier
Seiler, Roland; Thalmann, George; Zehnder, Pascal Claude (2013). Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution. Research and reports in urology, 2013(5), pp. 121-8. Dove Medical Press 10.2147/RRU.S32333
Seiler, Roland; von Gunten, Michael; Thalmann, George N; Fleischmann, Achim (2012). High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients. Human pathology, 43(2), pp. 269-75. Philadelphia, Pa.: Elsevier 10.1016/j.humpath.2011.04.030
Fleischmann, Achim; Rocha, Carla; Schobinger, Sylviane; Seiler, Roland; Wiese, Birgitt; Thalmann, George N (2011). Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases. Prostate, 71(5), pp. 453-60. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.21259
Seiler, Roland; Thalmann, George N; Fleischmann, Achim (2011). MMP-2 and MMP-9 in lymph-node-positive bladder cancer. Journal of clinical pathology, 64(12), pp. 1078-82. London: BMJ Publishing Group 10.1136/jclinpath-2011-200153
Fleischmann, Achim; Rotzer, Diana; Seiler, Roland; Studer, Urs E; Thalmann, George N (2011). Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. European urology, 60(2), pp. 350-7. Amsterdam: Elsevier 10.1016/j.eururo.2011.05.035
Seiler, Roland; von Gunten, Michael; Thalmann, George N; Fleischmann, Achim (2011). Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer. Histopathology, 58(4), pp. 571-8. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2559.2011.03778.x